|
Frequency of alleles at 26 single nucleotide polymorphisms in the promoter and coding region of pituitary growth hormone and the nucleotide present at the homologous site in other members of the human GH locus |
|||||||||
| Frequency |
GH1 paralogs |
||||||||
|
|
|
||||||||
| Position* |
Alleles |
This Study |
Horan et al. |
CS-5 |
CS-1 |
GH2 |
CS-2 |
Categorization |
Function** |
|
|
|||||||||
| -580 |
A |
0.985 |
A |
A |
A |
A |
Constant |
||
| G |
0.015 |
||||||||
| -476 |
A |
0.012 |
0.013 |
A |
G |
A |
G |
Variant |
|
| G |
0.988 |
0.987 |
|||||||
| -360 |
A |
0.972 |
G |
G |
G |
G |
Variant |
||
| G |
0.028 |
||||||||
| -352 |
G |
0.012 |
T |
G |
G |
G |
Variant |
||
| T |
0.988 |
||||||||
| -308 |
G |
0.732 |
0.753 |
T |
C |
T |
C |
Variant |
|
| T |
0.268 |
0.247 |
|||||||
| -301 |
G |
0.732 |
0.753 |
T |
T |
T |
T |
Variant |
|
| T |
0.268 |
0.247 |
|||||||
| -278 |
G |
0.628 |
0.601 |
T |
A |
T |
A |
Variant |
NF1 |
| T |
0.372 |
0.399 |
|||||||
| -168 |
C |
0.024 |
0.019 |
T |
C |
T |
C |
Variant |
|
| T |
0.976 |
0.981 |
|||||||
| -75 |
A |
0.900 |
0.886 |
G |
A |
G |
A |
Variant |
PIT-1 |
| G |
0.100 |
0.114 |
|||||||
| -57 |
G |
0.687 |
0.633 |
G |
T |
A |
T |
Variant |
Vitamin D Receptor |
| T |
0.313 |
0.367 |
|||||||
| -31 |
G |
0.882 |
0.867 |
G |
G |
- |
G |
Variant |
Vitamin D Receptor |
| - |
0.118 |
0.133 |
|||||||
| -6 |
A |
0.565 |
0.588 |
A |
G |
A |
G |
Variant |
Transcription Start |
| G |
0.435 |
0.412 |
|||||||
| -1 |
A |
0.847 |
0.932 |
C |
T |
A |
T |
Variant |
Transcription Start |
| C |
0.044 |
0.003 |
|||||||
| T |
0.109 |
0.065 |
|||||||
| 3 |
C |
0.044 |
0.003 |
C |
G |
G |
G |
Variant |
Transcription Start |
| G |
0.956 |
0.997 |
|||||||
| 16 |
A |
0.976 |
0.981 |
G |
A |
A |
A |
Variant |
5' UTR |
| G |
0.024 |
0.019 |
|||||||
| 25 |
A |
0.980 |
0.981 |
C |
A |
A |
A |
Variant |
5' UTR |
| C |
0.020 |
0.019 |
|||||||
| 59 |
G |
0.072 |
0.049 |
G |
G |
G |
G |
Variant |
5' UTR |
| T |
0.928 |
0.951 |
|||||||
| 69 |
A |
0.968 |
G |
C |
G |
G |
Variant |
Thr/Ala |
|
| G |
0.032 |
||||||||
| 124 |
A |
0.988 |
G |
A |
G |
A |
Variant |
Intron |
|
| G |
0.012 |
||||||||
| 128 |
A |
0.988 |
C |
C |
T |
C |
Variant |
Intron |
|
| T |
0.012 |
||||||||
| 140 |
A |
0.004 |
G |
G |
G |
G |
Constant |
Intron |
|
| G |
0.996 |
||||||||
| 144 |
A |
0.012 |
G |
G |
G |
G |
Constant |
Intron |
|
| G |
0.988 |
||||||||
| 281 |
C |
0.024 |
T |
C |
C |
C |
Variant |
Intron |
|
| T |
0.976 |
||||||||
| 596 |
C |
0.986 |
T |
T |
T |
T |
Variant |
Intron |
|
| T |
0.014 |
||||||||
| 1070 |
A |
0.004 |
G |
G |
G |
G |
Constant |
Synonymous |
|
| G |
0.996 |
||||||||
| 1169 |
A |
0.331 |
T |
T |
T |
T |
Constant |
Intron |
|
| T |
0.669 |
||||||||
|
* Relative to the start of transcription ** Polymorphisms in known transcription factor binding sites are shown. Site +69 is part of the signal peptide. | |||||||||
Adkins et al. BMC Pregnancy and Childbirth 2005 5:2 doi:10.1186/1471-2393-5-2 |
|||||||||